Archives Oligomerix Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer’s Disease November 11, 2010 By vera This article is sourced from an external publication. Read the original → ← PreviousSFN 2010 Press Release: Validation of Extracellular Tau Oligomer TargetNext →Oligomerix Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
